Background: Although poststroke depression has been shown to be related to decreased sexual activity (SA), the relationship between poststroke emotional incontinence (EI) and SA has not been properly investigated. Methods: We examined 70 nondepressed, sexually active patients with first-ever stroke approximately 3 months after stroke and conducted a follow-up interview approximately 2 years after stroke in 55 of them. EI (excessive/inappropriate laughing/crying) and SA (libido, coital frequency, erectile function) were assessed with the use of a standardized questionnaire. Results: Of these 70 patients, 24 (34%) had EI 3 months after stroke, which had resolved 2 years after stroke. Libido, coital frequency and erectile function were reported to have declined in 49, 65 and 26% of the patients, respectively, 3 months after stroke, and in 44, 49 and 20% of the patients 2 years after stroke. Multivariate analyses showed that low coital frequency before stroke (CFBS) was significantly (p < 0.05) related to decreased poststroke coital frequency, while the presence of EI (p < 0.05) and low CFBS (p < 0.05) was significantly associated with decreased erectile function 3 months after stroke. Two years after stroke, the presence of EI 3 months after stroke was significantly related to decreased libido, coital frequency and erectile function (p < 0.05 each). Age, gender, laterality of stroke, Barthel Index score, motor dysfunction and the presence of hypertension and diabetes mellitus were not independently related to SA 3 months and 2 years after stroke. Conclusion: The presence of EI is a factor related to decreased poststroke SA, more so in chronic than in subacute stages.

Keywords:
Sexuality, Emotion, Laughing, Crying, Cerebrovascular disease
1.
de Haan RJ, Limburg M, Van der Muelen JHP, Jacobs HM, Aaronson NK: Quality of life after stroke: Impact of stroke type and lesion location. Stroke 1995;26:403–408.
2.
King RB: Quality of life after stroke. Stroke 1996;27:1467–1472.
3.
Bray GP, deFrank RS, Wolfe TL: Sexual functioning in stroke survivors. Arch Phys Med Rehabil 1981;62:286–288.
4.
Monga TN, Lawson JS, Inglis J: Sexual dysfunction in stroke patients. Arch Phys Med Rehabil 1986;67:19–22.
5.
Coslett HB, Heilman KM: Male sexual function. Impairment after right hemisphere stroke. Arch Neurol 1986;43:1036–1039.
6.
Korpelainen JT, Nieminen P, Myllyla VV: Sexual functioning among stroke patients and their spouses. Stroke 1999:30:715–719.
7.
Fugl-Meyer AR, Jaasko L: Post-stroke hemiplegia and sexual intercourse. Scand J Rehabil Med Suppl 1980;7:158–166.
8.
Malone PE: A preliminary investigation of changes in sexual relations following strokes; in Brookshire R (ed): Clinical Aphasiology: Collected Proceedings. Minneapolis, BRK, 1975.
9.
Sjogren K: Sexuality after stroke with hemiplegia. II. With special regard to partnership adjustment and to fulfilment. Scan J Rehabil Med 1983;15:63–69.
10.
Boldrini P, Basaglia N, Calanca MC: Sexual changes in hemiparetic patients. Arch Phys Med Rehabil 1991;72:202–207.
11.
Morris PLP, Robinson RG, Raphael B: Emotional lability after stroke. Aust NZ J Psychiatry 1993;27:601–605.
12.
Ceccaldi M, Poncet M, Milandre L, Rouyer C: Temporary forced laughter after unilateral strokes. Eur Neurol 1994;34:36–39.
13.
Kim JS: Pathologic laughter after unilateral stroke. J Neurol Sci 1997;148:121–125.
14.
Kim JS, Choi-Kwon S: Poststroke depression and emotional incontinence: Correlation with lesion location. Neurology 2000;54:1805–1810.
15.
Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR: Pathological laughing and crying following stroke: Validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993;150:286–293.
16.
Gainotti G, Azzoni A, Razzano C, Lanzillotta M, Marra C, Gasparini F: The Post-Stroke Depression Rating Scale: A test specifically devised to investigate affective disorders of stroke patients. J Clin Exp Neuropsychol 1997;19:340–356.
17.
Goddess ED, Wagner NN, Silverman DR: Poststroke sexual activity of CVA patients. Med Aspects Hum Sex 1979;13:16–30.
18.
Sjogren K, Fugl-Meyer AR: Sexual problems in hemiplegia. Int Rehabil Med 1981;3:26–31.
19.
Sjogren K, Damber JE, Liliequist B: Sexuality after stroke with hemiplegia. I. Aspects of sexual function. Scand J Rehabil Med 1983;15:55–61.
20.
Ford AB, Orfirer AP: Sexual behavior and chronically ill patient. Med Aspects Hum Sex 1967;1:51–61.
21.
Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO: Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994;25:1050–1052.
22.
Derex L, Ostrowsy K, Nighoghossian N, Trouillas P: Severe pathological crying after left anterior choroidal artery infarct. Reversibility with paroxetine treatment. Stroke 1997;28:1464–1466.
23.
Jeret JS: Treatment of poststroke pathological crying (letter). Stroke 1997;28:2321–2322.
24.
Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS: Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci 1998;10:543–545.
25.
Bishop GA, Ho RH: The distribution and origin of serotonin immunoreactivity in the rat cerebellum. Brain Res 1985;331:195–207.
26.
Lavoie B, Parent A: Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol 1990;299:1–16.
27.
Palacios JM, Waeber C, Bruinvels AT, Hoyer D: Direct visualization of serotonin 1D receptors in the human brain using a new iodinated radioligand. Brain Res Mol Brain Res 1992;13:175–178.
28.
Luine VN: Serotonin, catecholamines and metabolites in discrete brain areas in relation to lordotic responding on proestrus. Neuroendocrinology 1993;57:946–954.
29.
Gorzalka BB, Mendelson SD, Watson NV: Serotonin receptor subtypes and sexual behavior. Ann NY Acad Sci 1990;60:435–446.
30.
Meston CM, Gorzalka BB: Psychoactive drugs and human sexual behavior. The role of serotonergic activity. J Psychoactive Drugs 1992;24:1–40.
31.
Musher JS: Anorgasmia with the use of fluoxetine (letter). Am J Psychiatry 1990;147:948.
32.
Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF: Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1990;51:25–27.
33.
Chandler BJ, Brown S: Sex and relationship dysfunction in neurological disability. J Neurol Neurosurg Psychiatry 1998;65:877–880.
34.
Fernandez-Guasti A, Rodriguez-Manzo G: Further evidence showing that the inhibitory action of serotonin on rat masculine sexual behavior is mediated after the stimulation of 5-HT1B receptors. Pharmacol Biochem Behav 1992;42:529–533.
35.
Vega Matuszcyk J, Larsson K, Eriksson E: The selective serotonin reuptake inhibitor fluoxetine reduces sexual motivation in male rats. Pharmacol Biochem Behav 1998;60:527–532.
36.
Rodriguez M, Castro R, Hernandez G, Mas M: Different roles of catecholaminergic and serotoninergic neurons of the medial forebrain bundle on male rat sexual behavior. Physiol Behav 1984;33:5–11.
37.
Svensson L, Hansen S: Spinal monoaminergic modulation of masculine copulatory behavior in the rat. Brain Res 1984;302:315–321.
38.
Burvill PW, Johnson GA, Chakera TMH, Stewart-Wynne EG, Anderson CS, Jamrozik KD: The place of site of lesion in the aetiology of post-stroke depression. Cerebrovasc Dis 1996;6:208–215.
39.
Ghika-Schmid F, Bogousslavsky J: Affective disorders following stroke. Eur Neurol 1997;38:75–81.
40.
MacHale SM, O’Rourke SJ, Wardlaw JM, Dennis MS: Depression and its relation to lesion location after stroke. J Neurol Neurosurg Psychiatry 1998;64:371–374.
41.
Starkstein SE: Mood disorders after stroke; in Ginsberg H, Bogousslavsky J (eds): Cerebrovascular Disease. Cambridge, Blackwell Science, 1998, pp 1168–1181.
42.
Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L: Risk factors for post-stroke depression. Acta Psychiatr Scand 1995;92:193–198.
43.
Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP: The Sunnybrook Stroke Study: A prospective study of depressive symptoms and functional outcome. Stroke 1998;29:618–624.
44.
Åström M, Adolfsson R, Asplund K: Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993;24:976–982.
45.
Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C: The role of serotonin in sexual dysfunction: Fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991;52:66–68.
46.
Buffum J: Pharmacosexology: The effects of drugs on sexual function, a review. J Psychoactive Drugs 1982;14:5–44.
47.
Balon R, Yeragani VK, Pohl R, Ramesh C: Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209–212.
48.
Monga TN, Ostermann HJ: Sexuality and sexual adjustment in stroke patients. Phys Med Rehabil State Art Rev 1995;9:345–359.
49.
Hayes V, Morris J, Wolfe C, Morgan M: The SF-36 health survey questionnaire: Is it suitable for use with older adults? Age Ageing 1995;24:120–125.
50.
McHorney CA, Ware JE Jr, Lu R, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.